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ABSTRACT
Thus far, identification of functionally important resi-
dues in Type II restriction endonucleases (REases)
has been difficult using conventional methods.
Even though known REase structures share a fold
and marginally recognizable active site, the overall
sequence similarities are statistically insignificant,
unless compared among proteins that recognize
identical or very similar sequences. Bsp6I is a Type II
REase, which recognizes the palindromic DNA seq-
uence 50GCNGC and cleaves between the cytosine
and the unspecified nucleotide in both strands,
generating a double-strand break with 50-protruding
single nucleotides. There are no solved structures
of REases that recognize similar DNA targets or gen-
erate cleavage products with similar characteristics.
In straightforward comparisons, the Bsp6I sequence
shows no significant similarity to REases with
known structures. However, using a fold-recognition
approach, we have identified a remote relationship
between Bsp6I and the structure of PvuII. Starting
from the sequence–structure alignment between
Bsp6I and PvuII, we constructed a homology model
ofBsp6Iand used ittopredictfunctionally significant
regionsinBsp6I.Thehomologymodelwassupported
bysite-directedmutagenesisofresidues predictedto
be important for dimerization, DNA binding and cata-
lysis. Completing the picture of sequence–structure–
function relationships in protein superfamilies
becomes an essential task in the age of structural
genomics and our study may serve as a paradigm
for future analyses of superfamilies comprising
stronglydiverged members with little or no sequence
similarity.
INTRODUCTION
Classical Type II restriction endonucleases (REases) are
homodimeric enzymes that recognize short DNA sequences
(typically 4–8 bp long) and in the presence of Mg
2+ cleave
the target in both strands at, or in close proximity to the
recognition site. Type II enzymes that exhibit structural and
functional peculiarities (requirement of more than one target
site for cleavage, cleavage at a distance from the asymmetrical
target, etc.) have been classiﬁed into subtypes [reviewed in
(1)]. Because of remarkably high speciﬁcity in recognizing
and cleaving their target sequences, they are of high interest as
model systems for analyzing protein–DNA interactions and
one of the most frequently used tools for recombinant DNA
technology.
In general, comparison of sequences of Type II REases
revealed little or no signiﬁcant sequence similarities, except
for groups of isoschizomers, i.e. enzymes that exhibit identical
recognition and cleavage speciﬁcities (2,3). This precluded
superfamily-wide sequence analysis using standard tools
for sequence alignment and raised the question of whether
the diversity of amino acid sequences of REases indicates
polyphyletic evolution (convergence) or extreme divergence
from the common ancestor (2,4). On the one hand, all crystal
structures of Type II REases solved to date share a 3D fold,
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doi:10.1093/nar/gki213which indicates that they are evolutionarily related [reviewed
in (5–7)]. On the other hand, a variety of sequence insertions
form a variable ‘shell’ surrounding that conserved core, which
indicates extensive divergence and explains problems with
sequence alignments (8). The active sites of enzymes, whose
structures have been solved, contain a (P)D-Xn-(D/E)-X-K
sequence signature, in which two acidic residues and Lys
are conserved. Some enzymes, however, have been shown
to deviate from this pattern of conservation [reviewed in (9)].
Recently, bioinformatics and biochemical studies provided
compelling evidence that some Type II REases belong
to unrelated superfamilies of nucleases: Nuc, HNH and
GIY-YIG (10–13). The lack of overall sequence conservation,
the absence of invariable residues even in the active site and
the presence of several alternative folds makes the structure
prediction of REases extremely difﬁcult.
Bsp6I is a Type II REase that recognizes the interrupted
palindromic sequence GCNGC and cleaves between the cyto-
sine and the unspeciﬁed nucleotide in both strands, leaving
50 overhangs of 1 nt. There are no available crystal structures
of REases that recognize similar sequences or produce an
identical pattern after cleavage. Furthermore, the Bsp6I seq-
uence shows no similarity to REases with known structures.
Therefore, Bsp6I is an example of a protein from the ‘twilight
zone’ ofthe evolutionary landscapeof the REase family.In the
absence of experimental structural information for Bsp6I, we
have built a homology model based on the structure of another
enzyme and used the model to guide experiments aimed at
identifying residues important for Bsp6I dimerization, DNA
binding and catalysis.
MATERIALS AND METHODS
Bioinformatics analysis
Sequence searches of the non-redundant (nr) database and
of the putative translations from ﬁnished and unﬁnished
microbial genomes were carried out using PSI-BLAST (14).
Secondary structure prediction of the protein fold-recognition
analysis (matching of the query sequence with known protein
structures) was carried out using the GeneSilico MetaServer
[with links to the individual methods provided in (15) and
at http://genesilico.pl/meta/]. The alignments between the
sequence of Bsp6I and the structure of PvuII were used to
carry out homology modeling using the ‘FRankenstein’s
Monster’ approach (16), which comprises cycles of generation
of local realignments in uncertain regions, building of alter-
native models and their evaluation using VERIFY3D (17),
realignment in poorly scored regions and merging of the
best scoring fragments.
In the model of the Bsp6I dimer, only the area of extensive
protein–protein contacts corresponding to the N-terminal
region was modeled explicitly, based on the structure of the
PvuII dimer (i.e. steric clashes were removed and interactions
between the protein side chains were optimized). Protein–
DNA interactions have not been modeled at the atomic
resolution, because they depend on the mutual orientation
of the central and C-terminal parts of the Bsp6I monomers,
whichcouldnotbepredictedwithsufﬁcientconﬁdence.Never-
theless, a low-resolution model of Bsp6I monomer–DNA
interactions was constructed based on the experimental data.
Bacterial strains and plasmids
Plasmid clones of mutant and wild-type (wt) genes of
Bsp6I were propagated in Escherichia coli XL1 Blue
MRF0 D(mcrA)183, D(mcrBC
  hsdSMR
  mrr)173, endA1,
supE44, thi-1, recA1, gyrA96, relA1, lac,[ F 0 proAB,
lacI
qZDM15, Tn10 (tet
r)] (Stratagene). lvir was used to test
restriction of infecting bacteriophages by the cells harboring
the wt Bsp6I and mutant proteins.
The Bsp6I producing plasmid pBsp6IRM2.1B (18) was
kindly provided by Dr Arvydas Janulaitis (Institute of Bio-
technology, Vilnius) andwas usedas avectorofwt and mutant
genes for in vivo experiments. An additional copy of the
bsp6IM gene had been provided on a plasmid pM.Bsp6IAC
constructed from a compatible vector pACYC184 (Cm
R)i n
order to increase the efﬁciency of establishment of the com-
plete restriction modiﬁcation (RM) system (18). Expression
plasmids (pBspRET) for protein overproduction and puriﬁca-
tion were obtained by amplifying pBsp6IRM2.1B insert (wt or
mutated) with oligonucleotides: Bsp6IRf, ATCCATGGCAC-
TACATGAT and Bsp6IRr, TTACTCGAGTAACTTGATA-
ATTTTCTTCGTTCG in a PCR reaction and cloning as NcoI–
XhoI fragments into the pET28a vector (Novagen), leading to
a C-terminal fusion of His6 tag to the recombinant Bsp6IR.
Strain E.coli DH10B (Invitrogen) carrying pM.Bsp6IAC was
used as a recipient.
Protein expression and purification
Recombinant Bsp6I proteins were overexpressed in E.coli
strain ER2566 F
  fhuA2 [lon] ompT lacZ::T7 gene1
gal sulA11 (mcrC
 mrr)114::IS10 R(mcr
 73::miniTn10–
TetS)2 R(zgb-210::Tn10) (TetS) endA1 [dcm] (New England
Biolabs) containing both pM.Bsp6IAC and pBspRET plas-
mids after 1 mM isopropyl-b-D-thiogalactopyranoside induc-
tion for 3–5 h at 37 C. Cell pellets were frozen-thawed and
lysed in buffer A (20 mM Tris, pH 8.0, 500 mM NaCl, 10 mM
b-mercaptoetanol, 10 mM imidazol, 1 mM phenylmethlysulf-
onyl ﬂuoride and 10% glycerol) by single passage through
French press at 20.000 psi. Clariﬁed lysates were batch
bound to His-Bind1 resin (Novagen) for 1 h at 4 C. After two
short washes with 10 vol of binding buffer, resin was applied
to empty disposable column and washed sequentially with
buffer A with 2 M NaCl and buffer A with 60 mM imidazol.
Puriﬁed enzyme was eluted with buffer A containing 250 mM
imidazol.
For circular dichroism (CD) analysis, the proteins eluted
from His-Bind1 resin (Novagen) were dialyzed to buffer B
(25 mM sodium phosphate buffer, pH 7.6, 0.3 M NaCl,
10% glycerol and 0.25 mM DTT) and further puriﬁed on
16/60 Superdex 75 PG gel ﬁltration column (Amersham
Pharmacia Biotech) equilibrated with buffer B. Fractions con-
taining the dimeric form of the enzyme were pooled and
concentrated with VivaSpin 6 concentrators (VivaScience).
Puriﬁed proteins were aliquoted and frozen at  70 C. Pro-
tein concentration was measured by Bradford assay with
NanoQuant kit (Roth) or by densitometry of Coomassie-
stained SDS–PAGE gels.
Site-directed mutagenesis of Bsp6I
Site-directed mutagenesis of the Bsp6I gene on the
pBsp6IRM2.1B plasmid was performed by a PCR-based
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system (Stratagene) following the manufacturer’s instruction.
The mutant genes were sequenced and found to contain only
the desired mutation.
In vivo analysis of the wt Bsp6I REase and the mutant
enzymes
Restriction of infecting lvir bacteriophages by wt and mutant
Bsp6I REase was assessed by measuring the titer of lvir phage
onE.colistrainXL1BlueMRF0 expressingtheBsp6Imethyl-
transferase (MTase) and comparing it with the wt or mutant
REase genes. The extent of phage restriction was determined
quantitatively by plating portions of serially diluted phage
stock on a lawn of bacteria (19). The strains were grown
on Luria–Bertani plates containing 50 mg/ml ampicilin and
20 mg/ml chloramphenicol. The ability to restrict lvir was
assessed by measuring the titer (from at least three independ-
ent measurements) of lvir phage on E.coli strain XL1 Blue
MRF0  expressing wt and mutant Bsp6I genes in the presence
of Bsp6I MTase and comparing it with a titer of phage on
the strain expressing only the MTase gene and containing the
pUC19 vector without the REase gene. Wt Bsp6I restricted the
phage growth by nearly four orders of magnitude (1100 –
80 plaques versus 7.9 · 10
6 – 4.2 · 10
5 plaques for the strain
expressing only the MTase gene).
In vitro analysis of the wt Bsp6I REase and selected
mutant enzymes
In vitro cleavage assays were set up in 10 ml vol of buffer R
(MBI Fermentas) (10 mM Tris–HCl, pH 8.5, 10 mM MgCl2,
100 mM KCl and 0.1 mg/ml BSA) with 0.3 mgo fl DNA
(dam
 , dcm
 ) (MBI Fermentas) as a substrate and serial
dilutions of puriﬁed REase. Digestion was performed for
1 h at 37 C. To compare digestion rates of the wt Bsp6I and
partially active E84A mutant, 611 bp PCR-generated fragment
of the pBluescript II KS(+) (Stratagene) plasmid with a single
Bsp6I site at position 217 was used as a substrate(the fragment
wasampliﬁedwithprimersMbspNlaF:TGCTCTTGCCCGGC
and MbspNlaR: GCCATCGCCCTGA). Activity tests were
carried out in duplicate with the substrate concentration of
20 ng/ml and with several enzyme concentrations, ranging
from 16 to 130 nM. For all concentrations, there was a linear
relationship between the reaction rate and the enzyme
concentration.
DNA-binding assay
Complementary oligonucleotides (50-GAAATGTGGAT-
GTAAAAGCAGCTAGCAATGATATTCCTGATAGTG-30)
containing Bsp6I recognition sequence (underlined) were
end-labeled with T4 polynucleotide kinase in the presence
of [g-
32P]ATP 6000 Ci/mmol (PerkinElmer, Life Science).
Following incubation for 1 h at 37 C, oligonucleotides were
puriﬁed by ethanol precipitation. Duplexes were formed by
heating equimolar mixtureofcomplementaryoligonucleotides
in the binding buffer [10 mM Tris–HCl, pH 8.5, 10 mM CaCl2
and 100 mM KCl] at 65 C for 2 min and then cooling down
slowly (for 1 h) to the room temperature. Binding reactions
contained20nMRE,1nMlabeledduplexwiththe recognition
sequence and 20 nM unlabeled duplex without the Bsp6I
recognition sequence (50-GTAATTACAGGAAATGTCGCG-
GTAAAAGCAACATCAAATG -30) in the binding buffer.
After 20 min binding at the room temperature, 50 ml aliquots
were ﬁltered in triplicate in dot-blot manifold (Scie-Plast)
through nitroclellulose ﬁlter (Schleicher and Schuell) equilib-
rated for 1 h in the binding buffer. Filters were washed three
times with 150 ml of the binding buffer, dried and exposed to
the PhosphorImager screen. The resulting image was scanned
on the Storm 820 PhosphorImager and the digitized image was
quantiﬁed with ImageQuant TL v.2003 software (Amersham
Biosciences). Intensities were corrected by subtracting the
background intensity measured without any protein present
in the binding reaction.
Circular dichroism
CD spectra were collected on the Jasco710 spectropolarimeter
with a temperature controller. The concentration of Bsp6I
dimer was 4 mM. Scans were collected at 20 C from 197 to
260, in 1 nm steps, using a 1 mm pathlength cuvette. Second-
ary structure content was estimated from the CD spectrum
using the CDpro server http://lamar.colostate.edu/~sreeram/
CDPro/main.html (20).
RESULTS
Database searches using PSI-BLAST (14) revealed sequence
similarity between Bsp6I, its isoschizomer LlaDII and a putat-
ive REase Sth242480IP (Figure 1); however, no signiﬁcant
similarity to other proteins could be detected, which is typical
for a highly divergent restriction enzyme. We chose to employ
a fold-recognition approach that potentially allows identiﬁca-
tion of homologs among the known structures even in the
absence of sequence similarity [reviewed in (21); for details
see Materials and Methods]. Among the fold-recognition
programs used to identify a homology modeling template for
Bsp6I, only two threading servers reported the PD-(D/E)XK
fold: 3DPSSM (22) recognized the PvuII structure (3pvi in
PDB) as the best template with a good score of 0.00759.
INBGU (23) reported the same structure, albeit with a low
score (3.6) at the sixth position of the ranking. Another
member of the PD-(D/E)XK fold, the N-terminal domain of
Rpb5 from Saccharomyces cerevisiae [1dzf (24)], was also
reported by INBGU, with a very low score of 2. None of the
potential templates reported by these and other servers gave a
score above the documented signiﬁcance level. Nevertheless,
among all protein structures reported, the consensus predictor
Pcons2 (25) singled out PvuII as potentially the best template
for homology modeling of Bsp6I. It is worth emphasizing that
the alignments of Bsp6I and PvuII sequences reported by
3DPSSM and INBGU agreed very well, with only the INBGU
alignment being incomplete at the C-terminus. Signiﬁcantly,
the hallmark of PD-(D/E)XK nucleases, i.e. the catalytic triad
D-E-K in PvuII appeared to be conserved in Bsp6I (Figure 1).
Modeling analysis using other possible templates (all reported
with low scores) revealed thatthe corresponding Bsp6I models
would be poorly folded, i.e. that no globular structure could be
constructed and/or hydrophobic regions would be exposed to
the surface. If these templates were enzymes, their catalytic
residues showed no conservation with relation to Bsp6I (data
not shown). Therefore, notwithstanding the low sequence
similarity between Bsp6I and PvuII and lack of statistical
support for the fold-recognition alignment (indicative of the
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as the most reasonable template for modeling of Bsp6I.
Structures derived from modeling usually contain inaccur-
acies, though they are often of good enough quality to putat-
ively identify regions important for function, which can then
be used to guide hypothesis-driven laboratory experiments.
The success of protein tertiary structure prediction by
homology modeling depends critically on the quality of the
underlying target-template alignment, because the standard
algorithms for model reﬁnement are unable to correct errors
resulting from misthreading (26). It is known that even if fold-
recognition algorithms identify the template with a correct
fold, they can produce inaccurate target-template alignments.
Thus, we used the ‘FRankenstein’s montster’ approach (16) to
build a homology model of Bsp6I using the coordinates of
PvuII as the template, and at the same time reﬁne the target-
template alignment by validation of the sequence-structure
ﬁt at the 3D level (for details see Materials and Methods).
The ﬁnal alignment and the corresponding model obtained
after several rounds of optimization guided by the structural
evaluation and validation with experimental data are shown in
Figures 1 and 2.
The catalytic site responsible for Mg
2+ binding and
phosphodiester bond cleavage
Several enzymatic mechanisms for Type II REases have been
proposed [reviewed in (27)]. In the context of PvuII, the
consensus mechanism involves two carboxylate groups of
Figure 1. Refined sequence alignment of Bsp6I and PvuII and their homologs. Amino acid residues are colored according to their physico-chemical features
(negative,red;positive,blue;hydrophobicandaromatic,gray;amide,darkred;smallhydrophilic,green;andpraline,violet).Similaroridenticalaminoacidresidues
are highlighted. Amino acid residues which were subjected to a mutational analysis in Bsp6I and shown to be essential or at least important are indicated above the
alignmentby‘d’,‘*’and‘c’(presumablyinvolvedindimerization,DNAbindingandcatalysis,respectively).Residuesshowntobenon-essentialareindicatedby‘+’.
Secondary structure (determined experimentally for PvuII and predicted for Bsp6I) is shown below the homologs of the target and the template.
Figure2. ComparisonofstructuresofthePvuIItemplateandthehomologymodelofBsp6I.(A)PvuIIdimercomplexedwithDNA(1pvi).Forclarity,onlythetarget
hexanucleotide duplex CAGCTG is shown (in cyan). (B) The final model of the Bsp6I dimer based on coordinates of PvuII (orientation of the monomers has been
based on the PvuII structure and not modified further). The protein backbone of two monomers is colored in green and blue. The side chains found to be important
for the activity of PvuII and Bsp6I are shown for one of the monomers; only the H85 pair (PvuII) is shown for both monomers. Residues involved in dimerization,
DNA binding and catalysis are colored in orange, magenta and red, respectively. The side chains non-essential for Bsp6I are indicated in gray.
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58 and E
68 that coordinate the Mg
2+ cofactor and an amino
group of K
70 that stabilizes the transition state and acts as a
Lewis acid in the reaction (27). The catalytic triad of PvuII
aligns with the corresponding triad (D
65,E
76 and K
78) in the
homology model of Bsp6I (Figures 1 and 2), suggesting that
thelattermaybeapartoftheactivesite.Totestthisprediction,
we have replaced these residues with alanine by site-directed
mutagenesis and tested the activity of the mutants in vivo. Our
operational criterion for an ‘essential’ residue is the reduction
oftherestrictionactivityfrom1.17·10
 4(wtBsp6I)toatleast
5 · 10
 1 in the alanine mutant, while mutations of ‘important’
residues reduce the activity by at least three orders of mag-
nitude, i.e. to the value between 1.17 · 10
 1 and 5 · 10
 1.I n
agreement with our model, D
65,E
76 and K
78 are essential for
Bsp6I activity in vivo (Figure 3). In PD-(D/E)XK enzymes,the
two consecutive antiparallel b-strands (amino acids 57–74 in
PvuII) that form the structural scaffold for the active site are
in a constant position relative to the three catalytic residues.
Hence, the similarity of the active sites of PvuII and Bsp6I
and the match of observed versus predicted secondary struc-
tures suggests that the core of Bsp6I (amino acids 64–82) has
been correctly identiﬁed by fold-recognition algorithms.
Regions involved in DNA sequence recognition
The co-crystal structures of PvuII–DNA, together with
mutagenesis studies, have implicated speciﬁc residues from
three regions in recognition of the C
1A
2G
3#C
4T
5G
6 sequence:
region I: Q33D34N35 in the loop between the ﬁrst two
a-helices; region II: S
81 followed by a His triplet
H
83H
84H
85; and region III: an Asn doublet N
140N
141 followed
by a K
143 residue (28–30).
In PvuII, region I constitutes the ﬂoor of the DNA-binding
cleft. Q
33 and N
35 make contacts with backbone phosphates,
while D
34 probably plays the main role in discrimination of
the central GC pair by interacting with the G
3 residue via the
minor groove (31). In Bsp6I, the sequence-region spanning
residues F
41-T
62 could not be aligned with conﬁdence with the
PvuII structure; however, the sequence and predicted structure
of the N-terminally located segment of Bsp6I (amino acids
D
16-N
40) unambiguously matched the dimerization helix of
PvuII (amino acids D
5-N
29) (Figure 1, also see below). Thus,
we regarded the conserved GIN
40 and GGDA
66 peptides
(GIN29 and GNDA
59 in PvuII) as qualiﬁed landmarks to
guide our efforts to ﬁne-tune the alignment in the uncertain
F
41-T
62 region of Bsp6I. We have built several homology
models of Bsp6I using alternative alignments of the segments
F
41-T
62 (Bsp6I) and D
30-E
55 (PvuII), with the additional con-
straint on deletions being limited only to the loop/bulge
regions in the PvuII structure (D
30-N
35 and L
51-E
55). Structure
evaluation using VERIFY3D (32) revealed that all models
except one exhibited negative scores in the F
41-T
62 region,
suggesting that the corresponding residues make improper
contacts (for instance, if too many polar residues are buried
and/or hydrophobic residues are exposed to the solvent). In the
only model, whose structure has been evaluated as reasonable,
region I of PvuII (QDN
35) corresponds to the ETI
45 tripeptide
in Bsp6I, in which the residue E43 is predicted to contact the
DNA. In agreement with this prediction, the E43A variant of
Bsp6I is inactive in vivo (Figure 3). This result provides strong
support for the proposed fold-recognition alignment of the
Bsp6I sequence with the PvuII region I structure and for
the resulting model. Moreover, none of the alternative models
revealed contacts between E43 and the DNA.
Regions II and III correspond to two recognition loops of
PvuII that contact DNA via the major groove (28). In region II,
substitutionof each ofthe four residues(S
81,H
83,H
84 and H
85)
interfered with catalysis; however, DNA binding was retained
Figure3. InvivolvirphagerestrictionactivityofBsp6Ivariantswithalaninesubstitutionsofresiduesofpresumptivefunctionalimportance(indicatedas‘catalysis’,
‘DNA binding’ and ‘dimerization’) and residues believed to be non-essential for the protein function.
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H84A mutants of PvuII exhibited reduction of the cleavage of
the unmodiﬁed DNA by  2 orders of magnitude (29). Inter-
estingly, the H84A mutant cleaved m
4C-modiﬁedDNA  50%
faster than the wt enzyme, suggesting that this residue is
involved in recognition of native DNA methylation (33).
H
85 in PvuII forms a hydrogen bond with H
85 from the
other subunit. This interaction between the PvuII monomers
is required to elicit phosphodiester bond cleavage (28,29).
Both 3DPSSM and INBGU fold-recognition methods
produced identical, gapless alignment of T
87-Y
114 from Bsp6I
with the T
77-Y
104 segment of PvuII. Notably, amino acids S
91,
S
93,E
94andN
95werepredictedbysecondarystructureanalysis
and homology modeling to constitute a region of Bsp6I that
corresponds to region II of PvuII (amino acids S
81,H
83,H
84
and H85). In agreement with this prediction, the in vivo cleav-
age activity of S91A and S93A mutants was signiﬁcantly
reduced. However, the E94A and N95A mutants retained a
substantial level of activity (Figure 3). It is noteworthy that
in PvuII the N-terminal part of region II (residues S
81 and H
83)
interacts with the DNA and does not participate in monomer–
monomer interactions, while the C-terminal part (residues H
84
and H
85) is involved in the formation of monomer–monomer
contacts in the protein–DNA complex (Figure 2). That the
effects of mutagenesis of PvuII and Bsp6I are similar in the
N-terminal part of region I and different in its C-terminal part
suggests that an alteration in the monomer–monomer inter-
actions has occurred in these two enzymes during evolution,
and it appears that this distribution of function has created a
local change in enzyme–DNA binding.
For the DNA recognition region III and neighboring
sequences, each fold-recognition method suggested a different
alignment with gaps or insertions in secondary structure ele-
ments. Such alignments caused disruption of the protein core
in preliminary models and were corrected manually. As for
region I, several alternative models were built with variations
in the underlying alignment. The target-template alignment
was guided primarily by matching hydrophobic amino acids
of Bsp6I with those involved in maintaining the hydrophobic
core in PvuII (Y
124,P
142,Y
148,V
149 and M
150). The model
with best VERIFY3D score was selected for experimental
veriﬁcation. Alanine substitution of bulky hydrophobic resi-
dues that are part of a protein core, regardless of position in the
sequence, might interfere with folding and thereby negatively
inﬂuence the catalytic activity. We therefore decided to test
our Bsp6I structural predictions by introducing mutations in
the counterparts of DNA-binding residues of region III
in PvuII. The correspondence between N
140,N
141 and K
143
in PvuII and R
142,R
143 and R
145 in Bsp6I became apparent
only after the model was built, since these residues were not
used to guide the reﬁnement of the target-template alignment
(Figure 1). Alanine substitution of R
142,R
143 and R
145 in
Bsp6I resulted in a greatly diminished enzyme activity in vivo
(Figure 3), which is in perfect agreement with our prediction
that these residues are the counterpart of DNA-binding region
III in Bsp6I. Conversely, other charged or polar residues from
the same region of Bsp6I that were predicted to be exposed
to the solvent, but remote from the DNA-binding site, and
hence not predicted to be important for the REase function
(Q
140 and E
154), could be substituted by alanine with only
minor effect on the Bsp6I activity (Figure 3, also see below).
Altogether, our experimental results provide strong support
for our theoretical model of Bsp6I structure. We believe that
the present model is accurate enough to allocate protein–DNA
contacts at the level of low to medium resolution, which is
sufﬁcienttoguidefurther,moresophisticatedanalyses,suchas
zero-length cross-linking. Figure 4 illustrates our prediction
of Bsp6I–DNA interactions, using the DNA molecule copied
from the PvuII complex. Since Bsp6I and PvuII recognize
different sequence targets and modeling of protein–DNA
interactions are at the brink of current techniques, we
considered modeling of the quaternary structure of the
Bsp6I–DNA complex at the atomic level as unreasonable
until more experimental data are available.
Amino acid residues involved in Bsp6I dimerization
Characteristic of all PvuII structures and missing from other
REase structures is the long N-terminal (amino acids 5–25)
kinked a-helix, which is swapped between the two monomers
and interacts with its counterpart from the other subunit and
with the second a-helix (amino acids 36–46). This structural
arrangement provides extensive points of contact between
subunits, thus stabilizing the mutual orientation of the
N-terminal subdomains (amino acids 1–47) of each monomer
near the minor groove of the recognition site, while the cata-
lytic core of each monomer (amino acids 48–157) retains
independent conformational freedom (28,34) . In Bsp6I, the
N-terminal region is also predicted to be a-helical like in
PvuII, and the fold-recognition algorithms used to predict
the structure of Bsp6I identiﬁed a number of hydrophobic
amino acid residues conserved between the two REases
(Figure 1), suggesting that they may exhibit similar inter-
subunit contacts on the minor groove side of the target DNA.
We analyzed the importance of hydrophobicity in N-terminal
residues for dimerization of Bsp6I by replacing them with
Figure 4. Predicted DNA-binding residues of Bsp6I in stereoview. The DNA
molecule (in gray) has been copied from the PvuII complex (1pvi) to illustrate
the general orientation of the enzyme and its target. The catalytic site and three
DNA-binding regions are indicated.
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exhibitedreduced REase activityin vivo (Figure 3), supporting
the prediction that tertiary and quaternary structures of PvuII
and Bsp6I possess similar N-terminal dimerization regions.
This is in contrast to the predicted dissimilarity of the inter-
subunit contacts on the major groove side of the target DNA,
suggested by different effects seen by mutating H
84 and H
85 in
PvuII (29) and compared with mutation of E
94 and N
95 in
Bsp6I (this work, see above).
To provide additional support for the predicted Bsp6I model
and eliminate the possibility that introducing alanine muta-
tions anywhere in Bsp6I would lead to reduced REase activity
in vivo, we selected several amino acids outside of known
critical regions to target for alanine mutagenesis. While the
amino acids selected are not predicted to be important for
Bsp6I folding or dimerization, they are in close proximity
to amino acids predicted to be required for Bsp6I function
(Figure 2). In accordance with our model, the substitution
of D84, D136, Q140 and E154 with alanine did not
substantially affect the REase activity of Bsp6I in vivo
(Figure 3). The congruence of fold-recognition and site-
directed mutagenesis suggests that the predicted model
of Bsp6I is a reasonable approximation of its native structure.
In vitro activity of selected Bsp6I mutants
To test whether restriction levels assayed in the phage plating
experiments parallel enzyme activity and do not reﬂect any
other possible side-effects of point mutations introduced (such
as decreased level of gene expression or protein misfolding
leading to insolubility and/or increased rate of degradation),
we assayed the in vitro activity of the wt Bsp6I and selected
mutant proteins after puriﬁcation. Mutants E76A (predicted
catalytic residue) and R143A (predicted DNA-binding resi-
due) were found to be completely inactive in vitro (<1% of
the wt Bsp6I activity) (Supplementary Material, Figure S1) in
agreement with the in vivo restriction assays. Mutants of non-
essential residues D84A andE94A retained substantial level of
enzymatic activity in vitro, in qualitative agreement with the
in vivo experiments. Their approximate in vitro activity meas-
ured on phage l DNA was 25 and 50% of the wt level, respect-
ively, whereas their in vivo restriction level was about one
order of magnitude lower than for the wt Bsp6I, 1.3 · 10
 3 and
1.1 · 10
 3, respectively (Figure 3). The steady-state cleavage
rate of a PCR-generated DNA substrate measured for the
D84A mutant was  40% of the cleavage rate determined
for the wt Bsp6I (Figure 5).
According to our model, observed inactivation of some
mutants results from the loss of a catalytic side chain and
in others–from the inability of the enzyme to recognize or
bind the speciﬁc substrate. We used the nitrocellulose ﬁlter
binding assay to study the ability to bind the speciﬁc DNA
target by representative mutants predicted to belong to these
two classes. The results shown in Figure 6 indicate that
mutation of a predicted catalytic residue E
76 leads to little,
if any, reduction of DNA binding, which is in line with results
obtained for catalytic residues of many other restriction
enzymes (35–37). On the other hand, mutation of a predicted
DNA-binding residue R
143 leads to a severe defect in DNA
binding, supporting the sequence-function relationships
inferred from the structural model of Bsp6I.
Comparison of the wt and mutant Bsp6I structure
using CD
Finally, we used CD spectroscopy to analyze the structure of
wt Bsp6I and to demonstrate that a point mutation in the
predicted active site (E73A), which completely inactivated
the enzyme, results in no gross conformational changes. The
CD spectrum of Bsp6I (Figure 7) is characteristic for proteins
with an a/b structure and shows two negative bands with
extrema in 208 and 220 nm (Figure 7). Using the CDPro server
(38), we estimated that the wt Bsp6I contains  25.4% of
a-helices and 25.1% of b-strands, which is in good agreement
with the values predicted based on the theoretical model:
31 and 26%, respectively. Importantly, we observed no sig-
niﬁcant change between the CD proﬁles of the wt Bsp6I and
the completely inactive mutant E73A (Figure 7). It suggests
that the secondary structure composition and presumably the
overall structure of the mutant protein is very similar to the wt
enzyme, and supports our prediction that E
73 is essential for
the catalytic activity of Bsp6I, but is not particularly important
for its structural stability.
DISCUSSION
Using fold-recognition, we detected structural similarities
between the monomers of Bsp6I and PvuII, despite that the
sequences of these enzymes are dissimilar. Model-based
prediction of key residues responsible for dimerization, DNA
binding and cleavage in Bsp6I has been conﬁrmed by site-
directed mutagenesis and in vivo analysis of the archetypal
function of the Type II REase, i.e. the ability to restrict the
growth of a lytic phage. These results support our assertion
that PvuII and Bsp6I share a PD-(D/E)XK fold, and a similar
mechanism of action.
Since PvuII and Bsp6I produce different ends after the
cleavage, the question arises whether the architecture of
the Bsp6I dimer at the active site is similar to that of PvuII.
The structure of PvuII has been solved in the absence [1pvu
(34)] and in the presence of DNA [1pvi (28)]. In the free PvuII
dimer, the catalytic cores (amino acids 48–157) of each
subunit are extended in an open state complex to allow DNA
binding. Upon DNA-binding, the catalytic cores clamp onto
the DNA by an  27  rotation around the DNA axis [super-
position of the Ca atoms revealed root-mean-square (RMS)
displacement of 7.92 s between 1pvu and 1pvi] and the
H85-H85 interaction is established between the two subunits
on the major groove side of the target DNA. The active
site residues of the PD-EXK motif are oriented differently
in the free enzyme compared with the enzyme complexed
with target DNA. In contrast, the extensive dimerization inter-
face formed by the N-terminal subdomain (amino acids 1–47)
on the minor groove side remains nearly identical (RMS
displacement of 1.33 s). The movement of the active sites
in relation to the N-terminal dimerization region is due to a
solvent-exposed loop comprising amino acids 46–49 that acts
as a hinge.
In the PvuII–DNA complex, the scissile phosphates are
‘facing each other’ in the two strands of the DNA target,
which results in ‘blunt’ cleavage, whereas the phosphodiester
bonds targeted by Bsp6I are separated by one non-speciﬁc
base pair, which is the source of 1 nt extension of the 50 end
Nucleic Acids Research, 2005, Vol. 33, No. 2 667generated after the cleavage. Among REases with known
structures, those similar to PvuII [i.e. the ‘b’ class of REases
(6,39)] typically produce blunt ends after the cleavage. One of
theexceptionsisBglI,whichevolvedtheabilitytoproduce3nt
30-staggered ends through an alteration of monomer–monomer
interactions (40). It is possible that Bsp6I evolved from a
typical ‘blunt-end cutting’ b-class ancestor similar to PvuII,
by modiﬁcation of its dimer structure, shifting the active sites
away from each other to ‘insert’ one non-speciﬁc base pair in
the middle of the recognition site. A similar scenario was
proposed for SsoII and NgoMIV, which generate 5 and 4 nt
staggered ends, respectively (41). However, it should be noted
that the target sequences of SsoII and NgoMIV contain com-
mon elements (two symmetrical C:G C:G base pairs), while
the targets of Bsp6I and PvuII do not. Hence, only a general
mechanistic model of the interaction of the Bsp6I dimer with
the DNA target can be proposed based on its predicted sim-
ilarities and differences with respect to PvuII. The proposed
evolutionofBsp6Iand PvuIIfrom acommon ancestor remains
Figure 5. DNA cleavage rate of the Bsp6I D84A mutant. (A) Gel assay of DNA cleavage. Numbers above lines indicate time (in minutes). M, molecular weight
standard;S,611bpPCR-generatedDNAsubstrate;andP,products(219and392bpfragments).(B)ComparisonofcleavageratesofthewtBsp6IandD84Amutant
measured in gel assays.
Figure 6. DNA-binding activity of two Bsp6I mutants. DNA-binding activ-
ities were measured using the nitrocellulose filter assay (see Materials and
Methods) in two independent experiments for alanine substitutions of E
76
(predicted to be a catalytic residue) and R
143 (predicted to be involved in
DNA recognition) of Bsp6I and are expressed as % of wt Bsp6I DNA binding.
668 Nucleic Acids Research, 2005, Vol. 33, No. 2hypothetical until more related sequences are identiﬁed and/or
when the crystal structure of Bsp6I is determined.
Our results provide a strong indication that the Bsp6I mono-
mer shares key structural and functional features with PvuII,
including a typical active site (D
65,E
76 and K
78), amino acids
involved in DNA binding and the N-terminal dimerization
helix. In addition, we identiﬁed a region in which apparently
homologous residues do not have the same function in PvuII
and Bsp6I. The function of PvuII amino acids H
84 and H
85
of PvuII in target recognition and stabilization of catalytic
domains of two monomers in a position suitable for the
‘blunt-end’ cleavage has not been retained in the correspond-
ing residues of Bsp6I, E
94 and N
95, which are dispensable for
the enzyme activity in vivo. We interpret these differences as
anindication ofachange inthe mutual orientation ofthe Bsp6I
monomers in its DNA-bound dimer form that has occurred
during evolution (Figure 8).
The structure of PvuII and our hypothetical model of Bsp6I
indicate that both REases resemble a kidney, with one end
elongated and the other ﬂattened; the concave surface between
the ends of the kidney-like structure is involved in DNA bind-
ing and cleavage. In the PvuII dimer, the monomers interact
tightly with each other through the elongated ends and weakly
within the ﬂattened ends. This allows the enzyme to encircle
the DNA in such a way that the minor groove is facing the
‘strong’interface betweenthe monomersandthe major groove
is facing the ‘weak’ interface. Based on the available data, we
propose that the orientation of Bsp6I monomers in complex
with the DNA can be deduced from the PvuII–DNA complex
by treating the two REase monomers as semi-ﬂexible moieties
‘glued’ to each other by the elongated ends and also separately
‘glued’ to the scissile phosphates (each monomer to one
strand). Insertion of 1 bp in the middle of the PvuII DNA
recognition sequence forces the scissile phosphates apart.
While the elongated ends remain ﬁxed in place, the ﬂattened
ends are shifted by a lever mechanism that changes their
relative position to each other and the DNA target. This mech-
anism can be used to explain why the protein–protein inter-
actions mediated by the N-terminal helices and protein–DNA
interactions mediated by the active site and the N-terminal
part of region II, respectively, are retained in PvuII and Bsp6I
(they correspond to the ‘glued’ parts), while at the same time,
the protein–protein and protein–DNA interactions mediated
by the C-terminal part of region II change (this region forms
the ﬂattened end).
Among the DNA-binding residues, S
91 and S
93 in Bsp6I
retain a similar orientation with respect to the recognition of
bases in DNA similar to what has been observed for S
81 and
H
83 in PvuII (reference). In contrast, E
94 and N
95 in Bsp6I
cannot make the equivalent contacts made by H
84 and H
85
in PvuII, because the mutual rotation of the two subunits
probably shifts the side chain of E
94 too far from the DNA
toallowspeciﬁc contacttobemade,andthepositionoftheN
95
side chains between subunits is too distant to provide the
equivalent contact observed between H
85 from the two sub-
units in PvuII (Figure 2A).
In PvuII, the middle guanine in the CAG#CTG sequence
is recognized by H
84 from the subunit that cleaves the
complementary strand. Assuming that the malleability of
the monomer is limited, residues in the vicinity of the active
site would retain the relative orientation and distance to the
active site, thus the homolog of H
84 should make contact with
the base whose phosphate group is liberated after cleavage, i.e.
‘N’ in the GC#NGC sequence recognized by Bsp6I. Appar-
ently, the side chain of E94 cannot ‘reach’ to the corresponding
base; hence, the base remains ‘unrecognized’. This suggests
E
94 as a tempting target for substitutions that may provide new
protein–DNA contacts and thereby generate an enzyme with a
novel speciﬁcity(witha deﬁned base insteadofNinGCNGC).
This, however, is beyond the scope of the present study.
CONCLUSIONS
Our work constitutes the ﬁrst attempt to predict structural
features of a Type II restriction enzyme in the so-called
‘twilight zone’ of homology (i.e. no statistically signiﬁcant
sequence similarity to known structures). We have previously
studied restriction enzymes by combination of modeling and
experimental analyses; however, in all these cases sequence
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Figure 7. CD spectra of the wt Bsp6I and the E76A mutant.
Figure 8. Proposed model of Bsp6I quaternary structure in relation to PvuII.
(A) A schematic diagram of PvuII dimer (monomers in black and gray)
complexed with DNA (white). The target sequence is shown. The scissile
phosphate is indicated by a shaded sphere. The side chains of H
84 (involved
in recognition of G residue in the opposite strand) and H
85 (involved in
dimerization) are indicated by arrows. (B) Model of the Bsp6I dimer; all
labels follow those for PvuII. The structurally mismatched residues E
94 and
N
95 are shown as ‘lollipops’. The non-specific base in the middle of the target
sequence is shown in gray.
Nucleic Acids Research, 2005, Vol. 33, No. 2 669similarities between the target and the template were more
pronounced (37,41–44). A similar approach to that described
in this work was used to predict the structure of PrfA protein
basedonthePvuIItemplate;however,theauthorsdidnotstudy
the dimerization mode and supported their model with only
one mutation of a predicted catalytic residue (45). The fold-
recognition analysis of Bsp6I described in this work was
used to design 18 alanine substitutions, in regions presumably
involved in dimerization, DNA binding, catalysis and in
regions presumed to be functionally non-important (as an
additional negative control). The mutant variants were tested
for the restriction activity in vivo. One caveat of protein
genetics is that inactivation by mutations may result from
gross structural aberrations in protein structure rather than
elimination of the function conferred by the particular side
chain. We do not believe this to be a major problem in our
study since 9 of 18 Bsp6I mutants analyzed here display a
measurable restriction level; hence, they are unlikely to
be misfolded. In addition, in vitro cleavage activities of all
selected mutants agree with their relative ability to restrict the
phage growth in vivo. Moreover, mutant E76A, which is com-
pletely inactive in the cleavage assay, maintains the wt level of
the DNA-binding activity, as commonly observed for catalytic
mutants of REases. Finally, CD spectra of the wt enzyme and
the E76A mutant are almost identical, indicating lack of gross
conformational differences in the inactive mutant.
Our initial model of Bsp6I based on the PvuII template was
in accordance with the experimental results, with the excep-
tion of the C-terminal part of region III. Upon consideration
of the experimental data and functional differences between
Bsp6I and PvuII, our ﬁnal model of the Bsp6I dimer now
agrees with all mutational data. We propose that the 3D fold
of Bsp6I is similar to the PvuII crystal structure, but these
enzymes differ somehow in the mutual position of the mono-
mers in the dimer. Despite its limitations, the present model of
Bsp6Iprovides insight intothe structural andfunctional organ-
ization of this enzyme and will guide future comparative
studies of REases. Our analysis can be regarded as a case
study of remote homology detection and structure prediction,
followed by model validation using a simple, low-resolution
experimental methodology. The prediction-validation
approach becomes increasingly important in the age of struc-
tural genomics, since only a fraction of protein structures
will be solved by crystallography, while others have to be
modeled using bioinformatics.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online and
the Bsp6I model is available from ftp://genesilico.pl/iamb/
models/R.Bsp6I/.
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